Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

COVID-19, other infections linked to major cardiovascular risks—researchers push for vaccination
Adults are three times as likely to have a heart attack or stroke after a COVID-19 infection than when they are healthy. The risks are even greater for the flu.
FDA clears new AI-enabled coronary plaque analysis software
Circle Cardiovascular Imaging, a Canadian medtech company, received the key approval for its cvi42 | Plaque platform.
A promising SELUTION: Sirolimus-eluting balloon from Cordis makes impression at TCT 2025
The SELUTION SLR Drug-Eluting Balloon was the topic of two different late-breaking clinical trials at TCT 2025. Both studies found that the device was noninferior to traditional treatments after one year. Long-term data are still needed.
Poor oral health tied to much higher risk of heart attack, stroke
Regularly going to the dentist, researchers added, may reduce cardiovascular risks by a significant margin.
PCI for eruptive calcified nodules: Drug-eluting stents, drug-coated balloons both linked to poor outcomes
In some cases, researchers noted, CABG may be a better treatment option. The group emphasized that alternative therapies are still needed to improve patient care.

Adding alirocumab to high-intensity statin therapy benefits older ACS patients

This new analysis of the ODYSSEY OUTCOMES trial includes data from more than 18,000 patients.

Unnecessary care: Levothyroxine ineffective for heart attack patients with subclinical hypothyroidism

The ThyrAMI-2 trial tracked 95 patients for 52 weeks of treatment.

New antiplatelet drug could be a breakthrough for heart attack patients

The peptide-derived drug, M3mP6 HLPN, prevents blood clots without increasing the risk of bleeding.

New risk score predicts number of cardiovascular-related deaths throughout US

The risk score was found to be considerably accurate, providing results that matched the work of prior researchers.

Breast cancer 60% more fatal for heart attack survivors

The eye-opening study tracked more than 1,700 patients with early-stage breast cancer.

Meet the gut bacteria that reduces heart disease risk

Researchers have identified bacteria in the human gut that could reduce a person’s risk of heart disease.

Cardiologist saves fellow hiker’s life—and then saves it again

Corey Adams, MD, saved a fellow hiker's life—and the story didn't end there.

Preterm births associated with increased risk of ischemic heart disease for the mother

The study's authors tracked data from more than 2 million women.

Acute Coronary Syndromes

COVID-19, other infections linked to major cardiovascular risks—researchers push for vaccination

FDA clears new AI-enabled coronary plaque analysis software

A promising SELUTION: Sirolimus-eluting balloon from Cordis makes impression at TCT 2025

Poor oral health tied to much higher risk of heart attack, stroke

PCI for eruptive calcified nodules: Drug-eluting stents, drug-coated balloons both linked to poor outcomes